Suppr超能文献

支持高钾血症管理策略的证据:一项系统的文献综述。

Evidence in support of hyperkalaemia management strategies: A systematic literature review.

作者信息

Palaka Eirini, Leonard Saoirse, Buchanan-Hughes Amy, Bobrowska Anna, Langford Bryony, Grandy Susan

机构信息

AstraZeneca Ltd, Cambridge, UK.

Costello Medical, Cambridge, UK.

出版信息

Int J Clin Pract. 2018 Feb;72(2). doi: 10.1111/ijcp.13052. Epub 2018 Jan 30.

Abstract

BACKGROUND

Hyperkalaemia is a potentially life-threatening condition that can be managed with pharmacological and non-pharmacological approaches. With the recent development of new hyperkalaemia treatments, new information on safe and effective management of hyperkalaemia has emerged.

OBJECTIVES

This systematic literature review (SLR) aimed to identify all relevant comparative and non-comparative clinical data on management of hyperkalaemia in adults. Our secondary aim was to assess the feasibility of quantitatively comparing randomised controlled trial (RCT) data on the novel treatment sodium zirconium cyclosilicate (ZS) and established pharmacological treatments for the non-emergency management of hyperkalaemia, such as the cation-exchangers sodium/calcium polystyrene sulphonate (SPS/CPS).

METHODS

MEDLINE, Embase and the Cochrane Library were searched on 3 April 2017, with additional hand-searches of key congresses and previous SLRs. Articles were screened by two independent reviewers. Eligible records reported interventional or observational studies of pharmacological or non-pharmacological management of hyperkalaemia in adults.

RESULTS

Database searches identified 2,073 unique records. Two hundred and one publications were included, reporting 30 RCTs, 29 interventional non-RCTs and 43 observational studies. Interventions investigated in RCTs included ZS (3), SPS/CPS (3), patiromer (4) and combinations of temporising agents (6 RCTs). A robust and meaningful indirect treatment comparison between ZS and long-established cation-binding agents (SPS/CPS) was infeasible because of heterogeneity between studies (including time points and dosing) and small sample size in SPS/CPS studies.

CONCLUSIONS

Despite hyperkalaemia being associated with several chronic diseases, there is a paucity of high-quality randomised evidence on long-established treatment options (SPS and CPS) and a limited evidence base for hyperkalaemia management with these agents.

摘要

背景

高钾血症是一种可能危及生命的病症,可通过药物和非药物方法进行治疗。随着高钾血症新疗法的近期发展,已出现有关高钾血症安全有效管理的新信息。

目的

本系统文献综述旨在识别所有关于成人高钾血症管理的相关比较性和非比较性临床数据。我们的次要目的是评估定量比较新型治疗药物环硅酸锆钠(ZS)与既定的用于高钾血症非紧急管理的药物治疗(如阳离子交换剂钠/钙聚苯乙烯磺酸钠(SPS/CPS))的随机对照试验(RCT)数据的可行性。

方法

于2017年4月3日检索了MEDLINE、Embase和Cochrane图书馆,并对主要会议和先前的系统文献综述进行了额外的手工检索。文章由两名独立评审员进行筛选。符合条件的记录报告了成人高钾血症药物或非药物管理的干预性或观察性研究。

结果

数据库检索识别出2073条独特记录。纳入了201篇出版物,报告了30项RCT、29项非RCT干预性研究和43项观察性研究。RCT中研究的干预措施包括ZS(3项)、SPS/CPS(3项)、帕替罗默(4项)以及临时用药的组合(6项RCT)。由于研究之间的异质性(包括时间点和剂量)以及SPS/CPS研究中的样本量较小,因此无法对ZS与长期使用的阳离子结合剂(SPS/CPS)进行稳健且有意义的间接治疗比较。

结论

尽管高钾血症与多种慢性疾病相关,但关于长期使用的治疗方案(SPS和CPS)的高质量随机证据匮乏,且使用这些药物进行高钾血症管理的证据基础有限。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验